Jean-christophe C. Philips

Liege, WAL, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Semaglutide for prevention of type 2 diabetes in women with postpartum prediabetes after gestational diabetes: protocol for a Belgian multicentre double-blind randomised placebo-controlled trial.

Semaglutide for prevention of type 2 diabetes in women with postpartum prediabetes after gestational diabetes: protocol for a Belgian multicentre double-blind randomised placebo-controlled trial.

Journal: BMJ open

Published: July 23, 2026

Impact of Technology Introduction on Glycemic Control of People Living with Type 1 Diabetes in Belgium: An Observational, Real-World Study.

Impact of Technology Introduction on Glycemic Control of People Living with Type 1 Diabetes in Belgium: An Observational, Real-World Study.

Journal: Diabetes technology & therapeutics

Published: July 02, 2026

Plea for an early diagnosis of people at risk of developing symptomatic type 1 diabetes

Plea for an early diagnosis of people at risk of developing symptomatic type 1 diabetes

Journal: Revue medicale de Liege

Published: September 11, 2025

Effectiveness of Conservative Treatment on Chronic Venous Disease Symptoms and Quality of Life in Patients with Type 2 Diabetes: Results from a Subanalysis of the VEIN STEP Observational Study.

Effectiveness of Conservative Treatment on Chronic Venous Disease Symptoms and Quality of Life in Patients with Type 2 Diabetes: Results from a Subanalysis of the VEIN STEP Observational Study.

Journal: Vascular health and risk management

Published: July 24, 2025

Impact of the era of diabetes onset in a national care system on the prevalence of retinopathy and microalbuminuria in people living with type 1 diabetes 15 years post-diagnosis: A cross-sectional, real-world observational study.

Impact of the era of diabetes onset in a national care system on the prevalence of retinopathy and microalbuminuria in people living with type 1 diabetes 15 years post-diagnosis: A cross-sectional, real-world observational study.

Journal: Diabetes, obesity & metabolism

Published: June 27, 2025

Glycemia risk index (GRI): a metric designed to facilitate the interpretation of continuous glucose monitoring data: a narrative review.

Glycemia risk index (GRI): a metric designed to facilitate the interpretation of continuous glucose monitoring data: a narrative review.

Journal: Journal of endocrinological investigation

Published: December 13, 2024

Finerenone and cardiorenal protection : from controlled clinical trials to real-life clinical practice

Finerenone and cardiorenal protection : from controlled clinical trials to real-life clinical practice

Journal: Revue medicale de Liege

Published: November 15, 2024

Continuous glucose monitoring for better glucose control in type 2 diabetes?

Continuous glucose monitoring for better glucose control in type 2 diabetes?

Journal: Revue medicale suisse

Published: September 02, 2024

Metabolic health in people living with type 1 diabetes in Belgium: a repeated cross-sectional study.

Metabolic health in people living with type 1 diabetes in Belgium: a repeated cross-sectional study.

Journal: Diabetologia

Published: May 16, 2024

Continuous glucose monitoring for the routine care of type 2 diabetes mellitus.

Continuous glucose monitoring for the routine care of type 2 diabetes mellitus.

Journal: Nature reviews. Endocrinology

Published: February 29, 2024

Gliflozins and finerenone: what are the prospects for their combination?

Gliflozins and finerenone: what are the prospects for their combination?

Journal: Revue medicale suisse

Published: August 23, 2023

Nasal glucagon (Baqsimi®), new treatment for hypoglycaemic coma

Nasal glucagon (Baqsimi®), new treatment for hypoglycaemic coma

Journal: Revue medicale de Liege

Published: September 09, 2022

Showing 1-12 of 28

Last Updated: 09/26/2026